Should You Buy Nutrien Stock on a Pullback?

Nutrien (TSX:NTR) stock has seen shares drop back by 24% from 52-week highs and by more than half since all-time highs. But now could be the time to buy.

| More on:
A steel grain silo storage tank with solar panel in a yellow canola field in bloom in Alberta, Canada.

Source: Getty Images

The once-great Nutrien (TSX:NTR) stock is down. But investors should think twice before counting it out. Despite reaching all-time highs of $148, the stock has now slumped by more than half to $70 per share as of writing. What’s more, the company fell by 24% since 52-week highs as well. Yet dig in, and investors may see this as more of an opportunity rather than a worry. So, let’s see why.

What happened?

First off, let’s look at what’s caused the drop in share price in the first place. Nutrien stock experienced a decline in operating margins over the last three quarters. Specifically, margins have decreased from 35% in the second quarter (Q2) of 2022 to 24% in Q4 2022. This contraction is primarily due to increased production costs and fluctuating fertilizer prices, which have squeezed profitability.

Furthermore, the prices of key fertilizers, including potash, nitrogen, and phosphate, have seen a moderation recently. This decline in prices is partly due to changes in global supply and demand dynamics, impacting Nutrien stock’s revenue and overall stock performance.

Fears of an economic recession have dampened the short- to medium-term demand outlook for fertilizers. This uncertainty has led to investor caution, contributing to the drop in Nutrien’s stock price. Although long-term demand prospects remain positive, the current economic climate has introduced volatility and risk.

Digging deeper

A lot of the issues then with Nutrien stock are more about broad market problems, not the stock itself. So, could the stock actually be a buy? To figure that out, we need to look at the company’s fundamental metrics.

First off, Nutrien stock offers a trailing 11.63 price-to-earnings (P/E) ratio and a forward 10.52 P/E ratio. These relatively low P/E ratios suggest that Nutrien might be undervalued compared to its historical performance and the broader market. A lower P/E can indicate a good buying opportunity if the company’s earnings are stable or expected to grow.

The company also provides a trailing price-to-sales (P/S) ratio of 0.83 and a forward of 0.91. A P/S ratio below one generally indicates that the stock is potentially undervalued relative to its revenue. This also makes it an attractive option for value investors.

Its current price-to-book (P/B) ratio of one suggests that the stock is trading at its book value, which might indicate a balanced valuation. As well, it holds a 4.26% dividend yield. A relatively high dividend yield can attract income-focused investors. Nutrien’s commitment to maintaining a strong dividend indicates financial health and a shareholder-friendly approach.

Nutrien stock also holds total debt of $13.64 billion, with a debt-to-equity (D/E) ratio of 0.55. While the company has significant debt, the D/E ratio indicates a moderate level of leverage, which can be manageable if the company continues to generate strong cash flows.

Finally, it holds an operating margin of 8.53%, a profit margin of 7.33%, and a free cash flow of $5.75. These metrics indicate that Nutrien is relatively efficient in generating profit from its operations and equity, which can be a positive sign for investors looking for stable returns. Strong free cash flow supports dividend payments and potential share buybacks, which can enhance shareholder value.

Is it a buy?

Altogether, Nutrien stock exhibits several positive attributes, such as a low P/E ratio, reasonable P/B ratio, and a solid dividend yield, making it potentially attractive for value and income investors. What’s more, analysts believe there is more to come. So, despite fears over potential macro issues in the future, on a micro level, Nutrien stock looks like one excellent buy during this pullback.

Fool contributor Amy Legate-Wolfe has no position in any of the stocks mentioned. The Motley Fool recommends Nutrien. The Motley Fool has a disclosure policy.

More on Dividend Stocks

ETF stands for Exchange Traded Fund
Dividend Stocks

Is the Average TFSA and RRSP Enough at Age 65?

Feeling behind at 65? Here’s a simple ETF mix that can turn okay savings into dependable retirement income.

Read more »

A worker drinks out of a mug in an office.
Dividend Stocks

3 No-Brainer TSX Stocks to Buy With $300

A small cash outlay today can grow substantially in 2026 if invested in three high-growth TSX stocks.

Read more »

dividend growth for passive income
Dividend Stocks

5 of the Best TSX Dividend Stocks to Buy Under $100

These under $100 TSX dividend stocks have been paying and increasing their dividends for decades. Moreover, they have sustainable payouts.

Read more »

shopper pushes cart through grocery store
Dividend Stocks

2 Dead-Simple Canadian Stocks to Buy With $1,000 Right Now

Two dead-simple Canadian stocks can turn $1,000 in idle cash into an income-generating asset.

Read more »

Child measures his height on wall. He is growing taller.
Dividend Stocks

2 Dividend Stocks to Create Long-Term Family Wealth

Want dividends that can endure for decades? These two Canadian stocks offer steady cash and growing payouts.

Read more »

beyond meat burger with cheese
Dividend Stocks

Invest $7,000 in This Dividend Stock for $359 in Passive Income

Here’s how this iconic Canadian brand could help you earn over $350 in annual passive income with a simple one-time…

Read more »

Paper Canadian currency of various denominations
Dividend Stocks

1 Marvellous Dividend Stock Down 5% to Buy and Hold Forever

A small dip in Fortis could be your chance to lock in a 50-year dividend grower before utilities rebound.

Read more »

Pile of Canadian dollar bills in various denominations
Dividend Stocks

3 Dividend Stocks to Buy Now for Less Than $50 

Investing $50 weekly can transform your financial future. Find out how to make the most of your investment strategy.

Read more »